Related Experiment Video
Updated: Jun 24, 2026
05:52
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Antipsychotics in the early stage of development
Falko Biedermann1, W Wolfgang Fleischhacker
1Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Tyrol, Austria. falko.biedermann@uki.at
Current Opinion in Psychiatry
|April 7, 2009
Summary
Recent pharmacological research for schizophrenia shows promising leads targeting neurotransmitter systems, though breakthroughs are limited. Future treatments may involve rational polypharmacy rather than a single "magic bullet" approach.
Area of Science:
- Psychopharmacology
- Neuroscience
- Schizophrenia Research
Background:
- Schizophrenia treatment remains a significant challenge with unmet needs, particularly for negative symptoms and cognitive impairment.
- Current pharmacological strategies often target dopamine and serotonin receptors, but novel approaches are being explored.
Purpose of the Study:
- To summarize recent pharmacological advancements in schizophrenia treatment.
- To review research on novel neurotransmitter receptor systems and alternative therapeutic strategies.
- To highlight efforts addressing negative symptoms and cognitive deficits.
Main Methods:
- Review of recent research findings in pharmacological approaches for schizophrenia.
- Analysis of studies targeting various neurotransmitter receptor systems.
- Exploration of alternative therapeutic strategies beyond direct central nervous system receptor modulation.
Main Results:
- Novel pharmacological leads show encouraging results in early-phase clinical trials, despite a lack of major breakthroughs.
- Approaches include modified dopamine/glutamate hypotheses and serendipitous discoveries.
- Traditional D2/HT2 receptor targeting compounds are still under investigation.
- Significant focus is placed on improving treatment for negative symptoms and cognitive impairment.
Conclusions:
- A single 'magic bullet' treatment for all aspects of schizophrenia is unlikely in the near future.
- Rational polypharmacy is predicted to be the leading trend in schizophrenia treatment over the next decade.
Related Concept Videos
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications